Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment

Effect of Treatment with Natalizumab on Ability to Work in People with Multiple Sclerosis

(2011) Sara Olofsson et al.   BIODRUGS

A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis

(2011) Carolina Holmén et al.   Multiple Sclerosis Journal

Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study

(2010) T. Olofsson et al.   ANNALS OF THE RHEUMATIC DISEASES

How long can you keep working with benign multiple sclerosis?

(2010) S. B. Glad et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Work ability: a new outcome measure in rheumatoid arthritis?

(2010) HG Raterman et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis

(2009) N. Putzki et al.   EUROPEAN JOURNAL OF NEUROLOGY

Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden

(2008) G Kobelt et al.   Multiple Sclerosis Journal